PedAM
Pediatric Disease Annotations & Medicines
| Disease | multiple sclerosis |
| Symptom | C0015672|fatigue |
| Sentences | 130 |
| PubMedID- 24251039 | fatigue in patients with multiple sclerosis (ms) is highly prevalent and severely impacts quality of life. |
| PubMedID- 22389829 | Interestingly, reduced thickness of the posterior parietal cortex in patients with multiple sclerosis has been associated with fatigue scores but, specifically, white matter lesions were not . |
| PubMedID- 21672300 | Which cognitions and behaviours mediate the positive effect of cognitive behavioural therapy on fatigue in patients with multiple sclerosis. |
| PubMedID- 25812128 | Diagnosis and quantification of cognitive fatigue in multiple sclerosis. |
| PubMedID- 25722532 | fatigue in patients with multiple sclerosis: is it related to pro- and anti-inflammatory cytokines? |
| PubMedID- 25386159 | Subjective cognitive fatigue in multiple sclerosis depends on task length. |
| PubMedID- 24453709 | Effect of eszopiclone on sleep disturbances and daytime fatigue in multiple sclerosis patients. |
| PubMedID- 23599993 | fatigue in multiple sclerosis: an overview of assessment and pharmacologic treatment. |
| PubMedID- 25145692 | Objective: to evaluate the neural basis of subjective fatigue in subjects with multiple sclerosis (ms) using a connectionist framework. |
| PubMedID- 22048931 | Measuring fatigue in persons with multiple sclerosis: creating a crosswalk between the modified fatigue impact scale and the promis fatigue short form. |
| PubMedID- 23949074 | Effects of ai-chi on balance, functional mobility, strength and fatigue in patients with multiple sclerosis: a pilot study. |
| PubMedID- 26004160 | Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica. |
| PubMedID- 20385911 | Relationship of cortical atrophy to fatigue in patients with multiple sclerosis. |
| PubMedID- 23153337 | The objective of the study was to investigate whether cognitive fatigue in patients with multiple sclerosis (ms) is a spontaneous phenomenon or whether it can be provoked or exacerbated through cognitive effort and motor exercise. |
| PubMedID- 24557490 | fatigue in multiple sclerosis (ms) may be attributed to a variety of biological and psychological factors. |
| PubMedID- 22183937 | Obstructive sleep apnea is associated with fatigue in multiple sclerosis. |
| PubMedID- 25309504 | Management of fatigue in persons with multiple sclerosis. |
| PubMedID- 24189209 | Cognitive fatigue in individuals with multiple sclerosis undergoing immunoablative therapy and hematopoietic stem cell transplantation. |
| PubMedID- 21118738 | Background: improvement of fatigue in patients with multiple sclerosis (ms) who were given bupropion has been previously reported, but scales for lethargy and depression were not used. |
| PubMedID- 21652611 | fatigue in multiple sclerosis: which patient should be referred to a sleep specialist. |
| PubMedID- 25066069 | A scoping review of rehabilitation interventions that reduce fatigue among adults with multiple sclerosis. |
| PubMedID- 21560176 | A pet study comparing multiple sclerosis subjects with and without fatigue also detected differences in extended prefrontal grey (gm) and wm (21). |
| PubMedID- 20100665 | fatigue in multiple sclerosis: mechanisms and management. |
| PubMedID- 20345240 | Measuring fatigue in patients with multiple sclerosis: reproducibility, responsiveness and concurrent validity of three dutch self-report questionnaires. |
| PubMedID- 26347062 | It appears to increase histamine in parts of the brain involved in controlling the sleep–wake cycle; however, knock-out mice that lack histamine receptors still show increased wakefulness with modafinil.38,39 the picture is also murky for modafinil’s effect on orexins, which are wakefulness molecules in the hypothalamus.40 modafinil has been shown to weakly bind to the dopamine transporter – like the stimulants,41 and dopamine transporter knock-out mice show no response to modafinil.42 a number of research studies have examined the benefit of these agents in fatigue associated with multiple sclerosis, tbi, cancer, and other conditions. |
| PubMedID- 25454981 | Objectives: sleep disturbances and fatigue are common in patients with multiple sclerosis (ms), but little is known about hypnotic use patterns in ms, or the relationship between these medications and fatigue. |
| PubMedID- 22935407 | fatigue in multiple sclerosis - a brief review. |
| PubMedID- 20815187 | fatigue in multiple sclerosis: mechanisms, evaluation, and treatment. |
| PubMedID- 25878696 | Comparing the effects of reflexology and relaxation on fatigue in women with multiple sclerosis. |
| PubMedID- 21210919 | The aim of this study was to obtain descriptions of the experiences of fatigue of people with multiple sclerosis, including experiences related to their interpersonal relations and social life. |
| PubMedID- 24952620 | Objective assessment of motor fatigue in multiple sclerosis: the fatigue index kliniken schmieder (fks). |
| PubMedID- 24250897 | Is anemia a probable cause of fatigue in patients with multiple sclerosis. |
| PubMedID- 24476345 | Objectives: the feasibility of a multimodal intervention and its effect on perceived fatigue in patients with secondary progressive multiple sclerosis were assessed. |
| PubMedID- 24453743 | Effect of a single bout of intermittent versus continuous walking on perceptions of fatigue in people with multiple sclerosis. |
| PubMedID- 22752539 | Objective: to develop and test the feasibility of an energy conservation programme to manage fatigue in multiple sclerosis. |
| PubMedID- 24363974 | Background: the aim was to explore the thalamo-striato-cortical theory of central fatigue in multiple sclerosis (ms) patients with self-reported fatigue. |
| PubMedID- 25748966 | fatigue in patients with multiple sclerosis: from movement preparation to motor execution. |
| PubMedID- 26078768 | According to a double blind controlled study, bemer therapy (2 × 8 minutes for 12 weeks) alleviated fatigue in patients with multiple sclerosis; subsequently, a 3-year open-label trial confirmed the long-term effect . |
| PubMedID- 24805128 | For example, we need to know whether the intervention shown to be effective for addressing fatigue in people with multiple sclerosis is also effective for people with other brain disorders such depression or stroke. |
| PubMedID- 21703724 | Effects of vibrotherapy on postural control, functionality and fatigue in multiple sclerosis patients. |
| PubMedID- 21467189 | The effect of exercise therapy on fatigue in multiple sclerosis. |
| PubMedID- 24013920 | Healthcare provider beliefs about exercise and fatigue in people with multiple sclerosis. |
| PubMedID- 24639657 | The skeletal structure was informed by prior research investigating fatigue for patients with multiple sclerosis (mills and young, 2008). |
| PubMedID- 21474627 | Neuroimaging by voxel-based morphometry: possible approach to finding the correlation between brain structural changes and fatigue severity in patients with multiple sclerosis. |
| PubMedID- 25170254 | Managing treatment fatigue in patients with multiple sclerosis on long-term therapy: the role of multiple sclerosis nurses. |
| PubMedID- 21203514 | Pbmc from 39 cfs patients, 50 multiple sclerosis patients with high fatigue scores (fss median 4.7, range 2.9-7.0) and 30 healthy volunteers were analyzed, of which the corresponding sera from 36 cfs patients, all 50 ms patients and 17 of the 30 healthy donors had already been tested by elisa (fig. |
| PubMedID- 25644133 | Disability, quality of life, personality, cognitive and psychological variables associated with fatigue in patients with multiple sclerosis. |
| PubMedID- 22766394 | Association of a deficit of arousal with fatigue in multiple sclerosis: effect of modafinil. |
| PubMedID- 22914848 | Impact of sleep disorder treatment on fatigue in multiple sclerosis. |
| PubMedID- 23151355 | Amantadine and the place of acupuncture in the treatment of fatigue in patients with multiple sclerosis: an observational study. |